GC Biopharma, the top pharmaceutical manufacturer of plasma products in Asia, is among the largest worldwide, distributing to more than 50 countries.

We are a global, values-based, R&D-driven biopharmaceutical leader with a large U.S. presence. We aim to discover and deliver lifetransforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.

Octapharma is the largest privately owned and independent plasma fractionator in the world. Our medicines are high-quality human proteins sourced from human plasma and human cell lines. We develop and manufacture medicines for patients in three therapeutic areas: hematology, immunotherapy and critical care.